Recently, Kexon Pharmaceuticals and Xinhua Pharmaceuticals reached a cooperation to sell ethyl eicosapentaenoate softgels overseas in Saudi Arabia and the United Arab Emirates. According to Kexon Pharmaceuticals, this is another important cooperation between the two sides after Sevelam Carbonate tablets, to jointly promote domestic high-purity EPA preparations into the two core pharmaceutical markets in the Middle East.

Recently, Kexon Pharmaceuticals and Xinhua Pharmaceuticals reached a cooperation to sell ethyl eicosapentaenoate softgels overseas in Saudi Arabia and the United Arab Emirates. According to Kexon Pharmaceuticals, this is another important cooperation between the two sides after Sevelam Carbonate tablets, to jointly promote domestic high-purity EPA preparations into the two core pharmaceutical markets in the Middle East.